# Alestramustine

> Mediated Wiki article. Canonical URL: https://mediated.wiki/source/Alestramustine
> Markdown URL: https://mediated.wiki/source/Alestramustine.md
> Source: https://en.wikipedia.org/wiki/Alestramustine
> Source revision: 1329020122
> License: Creative Commons Attribution-ShareAlike 4.0 International (https://creativecommons.org/licenses/by-sa/4.0/)

{{Short description|Chemical compound}}
{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = [(8''R'',9''S'',13''S'',14''S'',17''S'')-3-[''bis''(2-Chloroethyl)carbamoyloxy]-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] (2''S'')-2-aminopropanoate
| image = Alestramustine.svg
| image_class = skin-invert-image
| width = 250px

<!--Clinical data-->
| tradename = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration = 
| class = [Chemotherapeutic agent](/source/Chemotherapeutic_agent); [Estrogen](/source/Estrogen_(medication)); [Estrogen ester](/source/Estrogen_ester)

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion = 

<!--Identifiers-->
| CAS_number_Ref = 
| CAS_number = 139402-18-9
| CAS_supplemental = 
| ATC_prefix = 
| ATC_suffix = 
| PubChem = 20055302
| DrugBank_Ref = 
| DrugBank = 
| ChemSpiderID_Ref = 
| ChemSpiderID = 16736564
| UNII = 81U8A51CHK
| ChEMBL = 2106670
| synonyms = Alanylestramustine; Estradiol 3-(bis(2-chloroethyl)carbamate) 17β-(<small>L</small>-alaninate); Estradiol 3-(bis(2-chloroethyl)carbamate) 17β-(2β-aminopropanoate); Estradiol 3-(bis(2-chloroethyl)carbamate) 17β-((2''S'')-2-aminopropanoate)

<!--Chemical data-->
| C=26 | H=36 | Cl=2 | N=2 | O=4
| SMILES = CC(C(=O)OC1CCC2C1(CCC3C2CCC4=C3C=CC(=C4)OC(=O)N(CCCl)CCCl)C)N
| StdInChI_Ref = 
| StdInChI = 1S/C26H36Cl2N2O4/c1-16(29)24(31)34-23-8-7-22-21-5-3-17-15-18(33-25(32)30(13-11-27)14-12-28)4-6-19(17)20(21)9-10-26(22,23)2/h4,6,15-16,20-23H,3,5,7-14,29H2,1-2H3/t16-,20+,21+,22-,23-,26-/m0/s1
| StdInChIKey_Ref = 
| StdInChIKey = NRUFLTXGIPFVSH-KBVRNWHJSA-N
}}

'''Alestramustine''' ({{abbrlink|INN|International Nonproprietary Name}}), also known as '''estradiol 3-(''bis''(2-chloroethyl)carbamate) 17β-(<small>L</small>-alaninate)''', is a [cytostatic](/source/cytostatic) [antineoplastic agent](/source/antineoplastic_agent) which was never marketed.<ref name="NCI">{{cite web | title = Alestramustine | author = NCI Thesaurus | url = https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C77370 | access-date = 24 June 2016}}</ref><ref name="Milne2000">{{cite book| vauthors = Milne GW |title=Ashgate Handbook of Antineoplastic Agents|url=https://books.google.com/books?id=ZNkhAQAAMAAJ|date=1 July 2000|publisher=Wiley|isbn=978-0-566-08382-2|page=5}}</ref> It is the [<small>L</small>-alanine](/source/alanine) [ester](/source/ester) of [estramustine](/source/estramustine), which is a combination of the [nitrogen mustard](/source/nitrogen_mustard) [normustine](/source/normustine) coupled via a [carbamate](/source/carbamate) to the [estrogen](/source/estrogen_(medication)) [estradiol](/source/estradiol_(medication)).<ref name="NCI" /><ref name="Tripathi2013">{{cite book| vauthors = Tripathi KD |title=Essentials of Medical Pharmacology|url=https://books.google.com/books?id=FfG8AQAAQBAJ&pg=PA866|date=30 September 2013|publisher=JP Medical Ltd|isbn=978-93-5025-937-5|pages=866–}}</ref> Alestramustine acts as a [prodrug](/source/prodrug) to estramustine, and also forms estradiol as a [byproduct](/source/by-product).<ref name="NCI" /><ref name="Tripathi2013" /> The drug, via its [active metabolite](/source/active_metabolite)s, binds to [microtubule-associated protein](/source/microtubule-associated_protein)s and [β-tubulin](/source/tubulin) and interferes with [microtubule](/source/microtubule) function, thereby inhibiting [cell division](/source/cell_division).<ref name="NCI" /><ref name="Tripathi2013" /> Due to its estrogen [moiety](/source/moiety_(chemistry)), alestramustine is selectively concentrated in [estrogen receptor](/source/estrogen_receptor)-positive [cell](/source/Cell_(biology))s such as [prostate](/source/prostate) and [breast](/source/breast).<ref name="NCI" />

==See also==
* [List of hormonal cytostatic antineoplastic agents](/source/List_of_hormonal_cytostatic_antineoplastic_agents)
* [List of estrogen esters § Estradiol esters](/source/List_of_estrogen_esters)

==References==
{{Reflist}}

{{Estrogen receptor modulators}}

Category:Abandoned drugs
Category:Antineoplastic drugs
Category:Chloroethyl compounds
Category:Estradiol esters
Category:Estranes
Category:Hormonal antineoplastic drugs
Category:Nitrogen mustards
Category:Prodrugs
Category:Synthetic estrogens

{{Antineoplastic-drug-stub}}
{{Genito-urinary-drug-stub}}
{{Estrane-stub}}

---
Adapted from the Wikipedia article [Alestramustine](https://en.wikipedia.org/wiki/Alestramustine) by Wikipedia contributors ([contributor history](https://en.wikipedia.org/wiki/Alestramustine?action=history)). Available under [Creative Commons Attribution-ShareAlike 4.0 International](https://creativecommons.org/licenses/by-sa/4.0/). Changes may have been made.
